MONDAY, May 6, 2024 (HealthDay News) -- Parents of newborns diagnosed with cystic fibrosis often are confused about both the ...

(Reuters) - Vertex Pharmaceuticals beat Wall Street estimates for first-quarter profit on Monday, driven by robust uptake for ...

The cystic fibrosis leader reported higher-than-expected earnings and revenue.

By Paul Ziobro Vertex Pharmaceuticals posted double-digit sales growth in the first-quarter, topping Wall Street expectations, on continued growth of ...

We are all on high alert all the time.” Gibb is one of 11,000 people in the UK with cystic fibrosis, a genetic condition that leads to a build-up of mucus in the lungs and other organs. Most sufferers ...

The U.S. Food and Drug Administration's panel of independent advisers will on June 4 deliberate whether they should recommend ...

United Parcel Service said on Monday that its CFO and Executive Vice President Brian Newman would leave the company on June 1 ...

Qi "Tony" Zhou, a researcher in Purdue University's College of Pharmacy has received a $2.4 million grant from the National Institutes of Health to fight lung infections that have established a ...

All participants will be in a listen-only mode. [Operator instructions] After today's presentation, there will be an opportunity to ask questions. I would now like to turn the conference over to Ms.

Vertex Pharmaceuticals beat first quarter sales and earnings forecasts, but investors are closely watching its pipeline ...

The therapy is currently in late-stage development for the treatment of pulmonary arterial hypertension (PAH), which affects about 40,000 people in the United States. New York state sues group over ...

Vertex Pharmaceuticals (VRTX) Vertex Pharmaceuticals (NASDAQ:VRTX) has solidified its position as the leader in the treatment ...